CSb-9 increases albumin permeability of isolated glomeruli in vitro. Deposition of antibody and activation of the complement cascade are important in both naturally occurring glomerulonephritis and in experimental models including passive Heymann nephritis. We studied the effect of antibody and complement on albumin permeability of isolated glomernh to determine the role of the terminal complement components (C5-C9) in mediating the proteinuria in nephritis. Isolated glomeruli were treated with anti-Fxla (Heymann antibody) and then incubated them with pooled human serum, serum in which complement had been inactivated by heat,
or serum deficient in C6 or C7. The albumin reflection coefficient (oarnmjn) was calculated from the volumetric response of glomeruli to transcapillary oncotic gradients produced by albumin or high molecular weight neutral dextran (252 kD). Convectional permeability to albumin (Palbumin) was calculated as 1-aIbumin Albumin permeability of control glomeruli was not different from 0. Albumin permeability was not altered by antibody alone but was increased to 0.65 0.04 when antibody treated glomeruli were incubated for 10 minutes with pooled serum as a source of complement. Heat treatment of serum to inactivate complement prevented the increase in permeability. Incubation for 10 minutes with serum without antibody pretreatment caused a lesser increase in permeability of isolated glomeruli (0.18 0.06). Serum deficient in either C6 or C7 did not cause an increase in albumin permeability of antibody pre-treated glomeruli, but incubation with a combination of these sera (now containing the complete cascade) increased permeability to the same extent as did pooled normal serum (0.58 0.04). We conclude that activation of the terminal complement components is required for the increase in glomerular macromolecular permeability caused by anti-Fxla and that terminal complement activation is sufficient to alter the permeability independent of complement hemodynamic events or contribution by circulating cells.
Membranous nephropathy (MN) is a unique glomerular lesion characterized by diffuse deposition of IgG and complement in an exclusively subepithelial distribution [1] . These deposits induce a marked alteration in glomerular barrier function in the absence of any detectable inflammatosy cell infiltrate [1] . In rats, a lesion indistinguishable from MN can be induced by active or passive immunization to a crude kidney brush border membrane fraction termed Fxla (Heymann nephritis) [reviewed in 2] . Several studies over the past decade have shown that the subepithelial deposition of IgG in experimental MN results from the direct binding of antibody to antigen(s) expressed in the clathrin-coated pits along the membrane of glomerular epithelial cell (GEC) podocytes [reviewed in 2] . It is now well established that this proteinuria is mediated by the C5b-9 membrane attack complex of complement.
This hypothesis has been confirmed by studies of selective C6 depletion in two models of MN in the intact rat [3, 4] , of congenital C6 deficiency in a chronic serum sickness model of MN in the rabbit [5] , and of the requirement for C6 and C8 in the induction of proteinuria by anti-Fxla IgG in the isolated perfused rat kidney [6] .
While these studies provide strong evidence for a nephritogenic role for C5b-9 in mediating the injury induced by subepithelial immune complex deposits in several systems, analysis of the mechanism of this C5b-9 effect has been restricted by the limitations inherent in studying cellular events in a whole animal or whole organ system. Attempts to explore this issue by studying sublytic effects of antibody and C5b-9 on GEC in culture have yielded a substantial body of data demonstrating that C5b-9 results in increased intracellular calcium, activation of phospholipase C, increased levels of 1P2, 1P3, diacyl glycerol and phosphatidic acid with release of arachidonic acid, PGF2 and thromboxane [7] [8] [9] . However, there is currently no way to directly link these abnormalities induced by sublytic C5b-9 in cell culture with effects on glomerular permeability to protein in the intact glomerulus.
In the present study, we provide data on the effects of anti-Fx1A antibody and C5b-9 attack on the permeability barrier of the isolated normal rat glomerulus. This in vitro system permitted us to measure the albumin reflection coefficient (O•albumin) directly. The results confirm that C5b-9 plays an essential role in mediating injury induced by anti-Fx1A antibody and demonstrate that this effect occurs immediately. In addition, the data established that studies of albumin permeability of isolated glomeruli in vitro can be used to define the effects of individual inflammatory mediators on the integrity of the glomerular barrier to albumin.
Methods
Glomerular isolation and measurement of capillary volume response to oncotic gradients Glomeruli were isolated from the renal cortex of adult Sprague-Dawley rats (180 to 250 g body wt) using standard sieving techniques [10] . Isolation medium contained (in mmole/liter): sodium chloride, 115; potassium chloride, 5; sodium acetate, 10; dibasic sodium phosphate, 1.2; sodium bicarbonate, 25; magnesium sulfate, 1.2; calcium chloride, 1.0; and glucose, 5.5. The oncotic content of the medium was varied by the addition of bovine serum albumin (BSA), 1, 4, 6, 8 gIdl, (oncotic pressure, 2.3, 17.5, 24.8 or 37.7 mm Hg, respectively) or of high molecular weight neutral dextran, 252 kD, 1, 4, 6, 8 g/dl (oncotic pressure 3.25, 18.2, or 39.4 mm Hg). BSA was chosen because albumin is the molecule of interest in relation to glomerular injury and because it provides a sensitive probe for changes in the permeability barrier of the glomerular capillary. Neutral dextran of high molecular weight was chosen because data from sieving experiments indicate that the glomerular capillary remains impermeant to molecules of this size in both normal and proteinuric rats [11, 12] and in proteinuric humans [131. The oncotic pressure of the media was measured using a membrane oncometer (Wescor, Inc., Model 4100, Logan, Utah, USA). The membrane used had a molecular weight cut-off of 30 kD (Amicon PM 30, Amicon Division, W.R. Grace and Co., Beverly, Massachusetts, USA).
The volume response of the glomerular capillary volume to oncotic pressure gradients was examined in the following manner. Glomeruli were observed using videomicroscopy and glomerular volume was calculated from the average diameter measured from the video monitor. After an initial period of observation, the medium was replaced by fresh medium of different oncotic composition. Volume changes consequent to this alteration in medium composition occurred within five seconds and were maintained for at least several minutes in both control and experimental glomeruli. 0albumin was calculated from the glomerular volumes measured prior to and 30 seconds after medium exchange.
Measurement of albumin reflection coefficient and convectional permeability
The rationale and calculations for these measurements have been detailed elsewhere [14] . The following equation was used for the calculation of reflection coefficients:
This equation is valid when the arteriolar fragments are patent so there is no significant transcapillary hydrostatic pressure gradient. In this case, equilibrium, defined as Jv = 0, occurs when there is no significant oncotic gradient, that iS( TsoiuteTiute) = 0 [14] .
The response to iso-oncotic medium change was used to determine whether °albumin was less than 1.0. Glomeruli were isolated in 4 g/dl BSA medium and glomerular volume was measured. The bathing medium was then replaced with an albumin-free solution of neutral dextran of the same osmolality, lTdextran = albumin initial mediumS Following this exchange, equilibrium was rapidly re-established by movement of fluid across the glomerular capillaries. The new glomerular volume was stable within five seconds and remained unchanged for several minutes. If very little plasma protein was lost, it follows that albumhi = (Vcapiiiaayfinal/Vcapillaiy initial).
If albumin is equal to Udextran which is 1.0 for the large molecule used in these studies, the exchange of BSA medium for neutral dextran medium of the same oncotic pressure will not result in any net fluid flux or change in capillary volume. In contrast, j1 l7albumin is less than 1, capillary volume will decrease and equilibrium will occur at a diminished capillary and glomerular volume.
In selected conditions, volume responses to sequential changes of medium in which BSA or dextran was used to vary the oncotic pressure were used to calculate 0albumin The magnitude of the increase in glomerular volume following changes in bathing media depends on the physical properties of the glomerulus as well as on the permeability characteristics of the filtration barrier. There is a direct relationship between the increase in glomerular volume and the oncotic gradient applied across the capillary wall for both normal glomeruli and those in which permeability has been increased by incubation with protamine [12, 13] . In selected experiments, glomeruli were isolated in media with albumin concentrations up to 8 g/dl (38 mm Hg) or high molecular weight neutral dextran concentration of up to 6 g/dl (39 mm Hg).
Medium was replaced in step-wise fashion by solutions with lower concentrations of the same solute. Volume response was measured after 30 seconds. Since AV is proportional to (Osoiute7Tsoiute), and if dextran = 1, albumin = albumin for glomeruli in each experimental condition was calculated using the ratio of zW of experimental and control glomeruli exposed to identical gradients of BSA. In this case, we first determined that the volume responses of control and experimental glomeruli to neutral dextran were also the same, that is, Udextran = 1.0. In these experiments, 0albumin was calculated as: [14] Convectional permeability Convectional permeability was defined as COnvectional (1albumin) . This parameter describes the movement of albumin consequent to water flow and is distinct from diffusional permeability which is independent of solvent movement.
Induction of glomerular injury
The C5b-9 injury was induced by sensitizing freshly isolated rat glomeruli with sheep anti-Fx1A IgG and then exposing them to dilutions of fresh human serum as a complement source. Concentrations of anti-Fx1A IgG and human serum were chosen to induce sublytic C5b-9 injury. Anti-Fx1A IgG and normal sheep IgG were prepared from whole sheep serum or anti-serum as described in detail elsewhere [15, 16] . The same reagent has been utilized to induce proteinuria in the intact animal [15] . To determine an optimal concentration of antibody for use in these studies, rat GEC cultured as described elsewhere [17, 18] were incubated with anti-Fx1A IgG in concentrations from 0.5 to 10 mg/ml in cold verona! buffered saline at 4°C for 15 minutes. LDH release into the medium was measured using a colorimetric test kit (LDH-LD, Sigma Chemical Co., St. Louis, USA). Concentrations of less than 5 mg/ml were found not to cause cytotoxicity as documented by LDH release of less than 5% and Trypan blue exclusion of >95% [18] . A concentration of 4 mg/ml was utilized for the studies with isolated glomeruli. Similarly, GEC in culture were treated first with anti-Fx1A IgG (4 mg/mI) prior to incubation with dilutions of fresh, pooled human serum in verona! buffered saline as a complement source at 37°C for 30 minutes. A concentration of 2% vol/vol was found to be sublytic as defined by producing <5% LDH release and >95% Tiypan blue exclusion. Therefore, a 2% dilution of fresh human serum was used for the studies of isolated glomeruli.
For studies of albumin permeability, a suspension of freshly isolated normal rat glomeruli was incubated first with anti-Fx1A IgG or normal sheep IgG at a concentration of 4 mg/ml in 5 ml of isolation medium at 4°C for 15 minutes followed by two washes in isolation medium at 4°C and then incubation with 2% fresh or heat-inactivated (56°C, 30 mm) pooled human serum at 37°C for 15 minutes. The glomeruli were then exposed to oncotic gradients for permeability measurements. In some experiments, normal human serum was replaced with sera from patients known to be genetically deficient in C6 and C7 or in serum made from a 1:1 mixture of these two complement-deficient sera.
To determine whether the injury consequent to antibody and complement was related to cell lysis in intact glomeruli that did not occur in cultured cells, LDH release was measured in suspensions of isolated glomeruli using a commercially available kit (Sigma, DG134OK-UV). Three independent experiments were performed. LDH was measured after control incubation without serum or after pretreatment with anti-Fx1A and incubation in serum free medium or medium containing 2% vol/vol serum as a source of complement. LDH activity averaged 100 38 smol/ liter/min/1000 glomeruli after control incubation. LDH was not increased significantly by pretreatment with anti-Fx1A followed by incubation in serum-free medium or in medium with serum, averaging 100 47 and 99 35, respectively. In contrast, LDH after treatment with lysing buffer was 1500 445 imol/liter/min/ 1000 glomeruli (P < 0,001 vs. other groups, one way ANOVA).
Statistics
All values are expressed as mean SD unless stated otherwise. Statistical significance (defined as P < 0.05) was evaluated using the Student's t-test on one way analysis of variance with modified t-tests performed using the Bonferroni correction.
Results
Effect of anti-FxJA and complement on 0'albu,,ün Diminished 0'albumin was definitively documented in glomeruli isolated and incubated in medium containing 4 gJdl BSA, treated with anti-Fxla and complement, and then washed with iso-oncotic high molecular weight neutral dextran as an impermeant solute. Every glomerulus immediately lost capillary volume because the effective oncotic pressure of the dextran medium exceeded that of the initial BSA medium. The glomerular volume decrement averaged -4.2 0.3%, N = 7. In contrast, control glomeruli did not undergo any volume change under the same conditions. 0aIbumin for glomeruli incubated with anti-Fxla and complement was estimated from the concentrations of BSA and dextran that were isotonic to each other. This condition was met by BSA, 37.7 mm Hg and dextran 18.2 mm Hg; 0albmin calculated from these values was 0.48, albumjn = 0.52.
Increased albumin permeability was also evidenced by the finding that the volume response of glomeruli incubated with anti-Fxla IgG and serum to sequential albumin gradients was diminished compared to either the volume response of control glomeruli to albumin or dextran gradients or the response of experimental glomeruli to dextran gradients ( Fig. 1 a and b) . and the oncotic gradient as (1Tjjtjai -lTfinaI) Volume increment was directly proportional to the oncotic gradient and volume responses of control and experimental glomeruli were nearly identical. These findings support the hypothesis that incubation with anti-Fx1A and complement did not alter the relative capillary volume or the compliance of glomeruli. B. Volume response of control glomeruli and of glomeruli incubated with anti-Fx1A and pooled human serum to oncotic gradients of BSA. Volume responses of both control and experimental glomeruli to albumin gradients were directly proportional to the oncotic gradients. Volume response of experimental glomeruli was markedly diminished compared to that of control glomeruli, P < 0.05 vs. control. Thus, lb,,mn of glomeruli treated with anti-Fx1A and complement is markedly diminished. experimental glomeruli was used to calculate 0aIbumn and permeability for each experimental condition. Incubation of glomeruli in pooled normal human serum without prior exposure to antibody resulted in a time dependent decrease in °'albumin and increase in albumin permeability. Permeability was increased only slightly after 10 minutes (P = 0.18 0.06, N = 11) but was increased further after 20 or 30 minutes of incubation with serum (P = 0.40 0.10, N = 8 and 0.54 0.08, N = 16, respectively). Permeability was not increased by incubation with serum that had been heated to inactivate complement. Because complement alone produced significant injury, subsequent studies were done after 10 minutes of incubation.
Preincubation of glomeruli with anti-Fxla IgG in serum-free medium did not increase albumin permeability. The effects of treatment with anti-Fx1A and subsequent incubation with serum are shown in Figure 2 . Exposure of glomeruli to anti-Fx1A IgG followed by incubation in serum-free medium did not increase albumin permeability. Incubation of anti-Fx1A pretreated gbmeruli in medium containing heat-inactivated serum also had no effect on permeability (data not shown). In contrast, incubation of glomeruli pre-treated with anti-Fx1A in medium containing 2% pooled normal human serum markedly increased permeability. Serum deficient in either C6 or C7 did not cause an increase in albumin permeability of antibody pre-treated glomeruli (P = -0.13 0.15, N = 8 and -0.09 0.12, N = 11, respectively).
When C6 and C7 deficient sera were combined to reconstitute the complement system, injury identical to that which occurred in normal serum was observed (P 0.58 0.04, N 13).
Discussion Our results demonstrate that activation of C5b-9 by deposition of anti-Fxla antibody in vitro induces an immediate increase in glomerular permeability to albumin. Since the complement components C6 and C7 have no known biologic effects relevant to glomerular injury other than to support formation of the C5b-9 complex, we interpret the requirements for these precursor proteins to produce antibody-mediated glomerular injury in this system as documenting participation of C5b-9 in this process. No significant change in permeability occurred following incubation with large amounts of IgG antibody alone or following incubation of antibody-sensitized glomeruli with heat-inactivated serum devoid of complement activity. This requirement for C5b-9 to mediate proteinuria induced by anti-Fxla antibody confirms previous in vivo studies which have shown that selective C6 depletion abrogates development of proteinuria four days after antibody injection in the intact rat [3] and that proteinuria induced by anti-Fxla IgG in the isolated perfused rat kidney requires C6 and C8 [61.
The results of our studies also confirm our previous observa-tions that changes in glomerular volume in response to alterations in oncotic pressure gradients can be used to quantify the reflection coefficient for albumin across the glomerular capillary wall [141. A rigorous demonstration that 0albumin was less than 1.0 in glomeruli exposed to antibody and complement was derived from the finding that replacement of albumin medium by dextran medium of the same oncotic pressure resulted in an immediate loss of capillary volume. A numerical estimate of 0alhumin and of albumin permeability was made using the volume responses of normal glomeruli to albumin or dextran oncotic gradients. Glomeruli injured by incubation with complement alone or with complement after pre-incubation with anti-Fxla had volumetric responses to dextran that were comparable to those of untreated glomeruli.
This finding is consistent with the interpretation that the capillary volume available for exchange is about the same after antibody and complement treatment and that the compliance of the capillary is not markedly altered by these experimental treatments. In contrast, injured glomeruli had a diminished volume response to albumin gradients compared to either control gbomeruli or to responses of injured glomeruli to dextran gradients.
The values for albumin permeability that are reported here are much higher than those observed in any naturally occurring or experimentally induced renal disease during in vivo filtration and correspond to a sieving coefficient of 0.8, a value more than an order of magnitude larger than that observed in renal injury [14] .
This degree of injury would result in the loss of about 3 g of albumin/mm in a human with a normal GFR. The very high permeability may occur either because the injury produced in vitro may far exceed any that occurs in vivo or because the use of non-perfused and non-filtering glomeruli to define the °albumin may reveal a mechanism for protein permeability that has not been previously recognized. The discrepancy between aalhumjfl derived from in vivo and in vitro studies is only apparent in injured glomeruli. Further experiments will be required to determine which of the postulated explanations is correct. In the interim, however, diminished values of YaIhumin in vitro clearly indicate the presence of altered macromolecular permeability and provide us with a means to assess the degree of injury to the capillary filtration barrier in isolation from other potential mediators of injury.
An additional finding of some interest in the present study was that the C5b-9 induced change in albumin permeability in the isolated glomerulus was present at the earliest time point measured, 10 minutes after complement exposure. In contrast to the immediate sublytic effects of C5b-9 on GEC in culture, proteinuria induced by C5b-9 does not occur for three to four days following anti-Fxla antibody injection in the intact animal [18] and for about 20 minutes after initial antibody-complement exposure in the isolated perfused kidney [6] . This interval between initial antibody deposition with C5b-9 attack and the development of detectable functional changes in the permeability barrier has confused analysis of the relationship between known consequences of C5b-9 attack on the GEC and the development of proteinuria. Our study indicates that the functional consequences of C5b-9 attack on the GEC occur almost immediately in this system with no lag phase involved. Thus the delay in development of proteinuria in other models probably reflects the length of time required to deposit a nephritogenic quantity of antibody in the subepithelial space in the functioning kidney as well as the baseline increase in protein excretion which is seen in the isolated The nature of the cellular events induced by C5b-9 which lead to proteinuria have not been addressed by our studies, although the isolated glomerulus should provide a valuable tool to conduct such studies. Several possibilities merit consideration. C5b-9 stimulates production of proteases by mesangial cells in culture [19] . Proteases with GBM degrading properties are also made by glomerular epithelial cells and are released in increased quantities by glomeruli of rats with C5b-9 mediated PHN [20] . Similar proteases can induce increased albumin permeability in isolated glomeruli in vitro [21] . C5b-9 can also stimulate oxidant production by glomerular cells [22] . Increased oxidant production has been documented in C5b-9 mediated PHN [23] , and anti-oxidants reduced proteinuria in this model [24] [25] [26] . Oxidants also increase glomerular albumin permeability in our system in vitro [27] and account for the increased permeability induced by TNF which may be released in response to C5b-9 [28, 29] . Other molecules released in increased amounts by glomerular cells in response to C5b-9 such as prostaglandins [28, 30] , interleukins 1 and 6 [31] , and extracellular matrix components [32] , seem less likely than oxidants or proteases to mediate the immediate change in gbmerular albumin permeability induced by C5b-9 in our studies.
The phenomenon of altered glomerular permeability induced by C5b-9 in normal glomeruli incubated with complement alone also merits comment. Our previous studies have established that kidney cells damaged by a variety of mechanisms can serve as activators of the alternate complement pathway leading to C5b-9 formation [33, 34] . Although isolated glomeruli, as in this study, appear relatively intact by both structural and functional measures [10] , some damage to the resident epithelial cell layer probably occurs. Such damaged cells, or cell fragments, may induce local C5b-9 formation [33, 34] . C5b-9 attack on nearby viable cells would then occur in quantities that may be sufficient to produce injury [35] . Our studies provide the first evidence that such C5b-9 formation may be sufficient to induce an abnormality in glomerular function.
In summary, our studies provide evidence for a direct effect of C5b-9 activated by both antibody deposition and non-immune processes on the permeability of the normal glomerulus to albumin. They further establish the utility of the isolated glomerulus as a tool for studying the effects of various immune events on glomerular permeability to protein and document the feasibility of this technology for examining the link between cellular events produced by inflammatory mediators including antibody, complement and various cytokines and the functional consequences of these effects which result in disease manifestations such as proteinuria.
